Healthcare provider information sheet for acinetobacter. Although other species of acinetobacter are also often associated with hais. However, acinetobacter was identified as a lowvirulent pathogen, which infects mostly immunocompromised hosts. Research article control of an outbreak of acinetobacter. Mortality rates associated with multidrugresistant. Acinetobacter baumannii has emerged as an important nosocomial pathogen. This strain spread rapidly and caused a large outbreak in the hospital.
In germany, to date, little is known on the extent of mdr in a. A team of australian and portuguese investigators has discovered yet another resistance mechanism in the pathogen, acinetobacter baumannii, in this. Complete genome of the multidrugresistant acinetobacter. The risk factors and spread of multidrugresistant acinetobacter baumannii in intubated patients in a medical intensive care unit aim. Among all gramnegative bacteria, acinetobacter baumannii is an emerging pathogen that accounts for about 80% of all reported infections. Multidrug resistant acinetobacter baumannii isolates from. Antibioticresistant acinetobacter baumannii increasing success. Multidrugresistant acinetobacter baumannii medscape. Since the 1970s, the spread of multidrugresistant mdr acinetobacter strains among critically ill, hospitalized patients, and subsequent epidemics, have become an. New resistance mechanism in the often multidrug resistant. Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the healthcare community.
Multidrugresistant acinetobacter baumannii volume 11. It is difficult to control, and the infections caused by it are difficult to treat, because it is multidrug resistant. The challenges of treating multidrugresistant bacteria continue to be at the forefront of the clinicians practice in caring for hospitalized patients. It involved identification of clinically recovered a. Treatment of acinetobacter infections oxford academic. However, the presence of mdra was confirmed in our hospital, after isolation from the sputum of a patient who had received treatment for cerebral infarction at a hospital in a neighboring country, and then was admitted to our hospital after. A total of 5,058 patients cultured positive with a.
We describe the systematic investigation initiated to discover an environmental reservoir and a novel measure taken to terminate the outbreak. Control of hospital endemicity of multipledrugresistant. Acinetobacter baumannii, most often multidrug resistant, is a difficult to treat pathogen particularly in intensive care units icus of a hospital. Acinetobacter baumannii, a gramnegative opportunistic pathogen in humans. Pdf acinetobacter baumannii, a nonmotile, glucose non. The current study investigated the emergence of colistin resistance among carbapenemresistant strains of a.
The drugresistant nature of the pathogen and its unusual and. The global emergence of multidrug resistant acinetobacter baumannii has reduced the number of clinically available antibiotics that retain activity against this pathogen. Acinetobacter baumannii, a strictly aerobic, nonfermentative, gramnegative coccobacillary rodshaped bacterium, is an opportunistic pathogen in humans. Characteristics of multidrugresistant acinetobacter. Studies have demonstrated that fosfomycin is a promising drug, particularly in combination with other. The aim of this study was to determine the prevalence and increasing antibiotic resistance of a.
Oligonucleotide arraybased identification of species in. Although there have been many genomic studies on the evolution and antibiotic resistance of this species, there have been very limited transcriptome studies on its responses to antibiotics. Successful control of an acinetobacter baumannii outbreak in a neonatal intensive care unit. Pdf acinetobacter baumannii, most often multidrug resistant, is a difficult to treat pathogen particularly in intensive care units icus of a. Acinetobacter baumannii has been reported increasingly as a significant. For this reason, the development of novel treatment strategies for infections.
Acinetobacter baumannii has proven to be an increasingly important and demanding species in health careassociated infections. Prevalence and resistance profile of acinetobacter. Multidrug resistant acinetobacter baumannii, mrab is an important cause of hospital acquired infection. Analysis of tigecycline resistance development in clinical. Ijerph free fulltext infection control programs and. Methods strains and growth conditions the study included 27 nonduplicate multidrugresistant a. Acinetobacter baumannii has been reported increasingly as a. In february 2006, a patient colonized with a multidrugresistant sequence type 56 acinetobacter baumannii strain was admitted to a hospital in madrid, spain. Treatment is complicated by multidrugresistance mdr. Bacteremia due to acinetobacter baumannii complex abc, which composed of four genomic species gen. Investigation of the infection control approach against. Its ability to survive in a hospital milieu and its ability to persist for extended periods of time on surfaces makes it a frequent cause for healthcareassociated infections and it has led to multiple outbreaks.
This protective effect was significant after confounding. We investigated 118 patients, on 27 wards, in whom mdr a. Longitudinal multicenter surveillance data on abc from different sources in taiwan have not been published. Acinetobacter baumannii complex abc has emerged as an important pathogen causing a variety of infections. The mechanisms of drug resistance acquisition in a. Old antibiotics, such as fosfomycin and polymyxins, are now considered potential treatment alternatives to overcome the lack of new antibiotics 24. Acinetobacter baumannii in intensive care units icus are increasing ji ye et al. Since the 1970s, the spread of multidrugresistant mdr acinetobacter strains among critically ill, hospitalized patients, and subsequent epidemics, have become an increasing cause of concern. The epidemiology, risk factors, and infection control measures to prevent nosocomial transmission of this epidemic clone were analyzed. While there are many species of acinetobacter that can cause human disease, acinetobacter baumannii a. This retrospective study was conducted to determine the prevalence and antibiotic resistance pattern of a.
Clinical manifestations, antimicrobial therapy, and prognostic factors. Analysis of the extracellular proteome of colistin. Pdf prevalence of multidrug resistant acinetobacter baumannii in. An outbreak of multidrugresistant acinetobacter baumannii. Multidrugresistant acinetobacter baumannii infection following paraarticular steroid injection in the knee.
Therefore, it is considered as a new threat in hospitals, which requires a. Acinetobacter baumannii is the most common nosocomial pathogen among all acinetobacter spp. An array with six oligonucleotide probes based on the 16s23s rrna gene intergenic spacer its region was developed to differentiate species in the a. Colistin is one of the promising options for treatment of multidrugresistant a. A 5year surveillance study on antimicrobial resistance of. The aim of this study was to determine the incidence and mortality of this multiresistant strain of acinetobacter in patients undergoing cardiac surgery, to elucidate the effectiveness of treatment with colistin and to. After the outbreak was halted in late october, the number of cases of mdrab remained somewhat elevated in november because of an. The spread of multidrugresistant acinetobacter baumannii mdra has become a global concern, but detection of mdra is comparatively rare in japan. Isolation and identification of multidrug resistant. The acinetobacter species cause infections, which are associated with increased morbidity and mortality rates 4. Multidrugresistant acinetobacter baumannii, a major hospitalacquired pathogen, is a serious health threat and poses a great challenge to healthcare providers. Antimicrobial susceptibility of acinetobacter baumannii isolated from hospital patients. The purpose of this study is to determine the risk factors for mrab in a city hospital patient population.
Manca1 institute of microbiology, university of brescia, italy. Most of the isolates were obtained from rectal swabs of. Prevalence of multidrugresistant acinetobacter baumannii. Gramnegative bacilli including multidrugresistant acinetobacter baumannii mdrab are responsible for severe icuacquired infections, mainly pneumonia and bacteraemia. Acinetobacter baumannii can cause severe infections, mainly in critically ill inpatients. Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrugresistant mdr acinetobacter baumannii, according to a. Journal of infection and public health 20 6, 179185 prevalence of multidrugresistant acinetobacter baumannii and pseudomonas aeruginosa in an italian hospital m. Emergence of extensivelyresistant acinetobacter baumannii. To understand the epidemiology of multidrugresistant mdr acinetobacter baumannii and define individual risk factors for mdr, we used epidemiologic methods, performed organism typing by pulsedfield gel electrophoresis pfge, and conducted a matched casecontrol retrospective study. The patterns indicate various strains of multidrugresistant acinetobacter baumannii mdrab as defined by pulsedfield gel electrophoresis. Emergence of extensively drugresistant acinetobacter. Abstract acinetobacter baumannii is an emerging gramnegative nosocomial pathogen that rarely causes infections in or. Appropriate selection of antibiotics for the treatment of the majority of severe microbial infections.
Although controlling the transmission of mdrab is a high priority for institutions. The incidence of multidrugresistant acinetobacter baumannii mdr a. Multidrug resistant acinetobacter baumannii inside and outside hospital setting. Epidemiological characteristics and drug resistance. Acinetobacter baumannii has emerged over the last decade as a significant opportunistic pathogen and primarily associated with hospitalacquired infections. In order to better understand transmission and evolutionary dynamics of mdr acinetobacter baumannii ab during longterm infection, we analyzed genomes from a series of isolates from individual. The purpose of this study was to evaluate the prevalence, biotyping, and antibiotic resistance status of a. Management of multidrugresistant acinetobacter spp.
Acinetobacter baumannii is one of the most common causes of ventilatorassociated pneumonia in intensive care units. Antimicrobial susceptibility of acinetobacter baumannii. Multidrugresistant acinetobacter baumannii mdrab was found in the environment of 48 percent of the rooms of patients colonized or infected with the pathogen, according to a new study. Introduction the extensive use of antibiotics and the gradual increase of different types of drugs have made bacteria resistant to drugs 1,2. Research multidrugresistant acinetobacter baumannii. Acinetobacter is nonmotile, obligate aerobic gramnegative coccobacillus and are ubiquitous freeliving saprophytes in soil and water. The aim of this study was to determine the risk factors for colonization in the. Multidrug resistant acinetobacter baumannii in veterinary. The epidemiology of multidrugresistant acinetobacter baumannii.
Limited treatment options are available for patients infected with multidrug mdr or pandrug pdrresistant bacterial pathogens, resulting in infections that can persist for weeks or months. Epidemiology of mrab survival in the environmental conditions, including seawater especially in the warm period of the year up to 50 days, may also. A retrospective analysis of carbapenemresistant acinetobacter. Acinetobacter is a gramnegative bacterium commonly found in soil and water. Multidrugresistant acinetobacter baumannii is an important bacterium causing nosocomial infections. Infections caused by multidrugresistant acinetobacter baumannii have emerged as a serious problem throughout the world. Multidrugresistant acinetobacter baumannii found growing.
An increasing endemicity of multipledrugresistant acinetobacter baumannii mrab st457 was noted in hong kong. Prevalence of multidrug resistant acinetobacter baumannii. Among them, acinetobacter baumannii, a ubiquitous, strictly aerobic, nonfermentative coccobacillus, has emerged. Melamed r, greenberg d, porat n, karplus m, zmora e, golan a, et al. Multidrugresistant acinetobacter baumannii susceptible. The outbreak period was in september and october 2003, when a marked increase in the number of cases was noted. Between june 1, 2004, and march 14, 2005, 16 patients in the surgicalmedical intensive care unit icu were infected and another 2 were colonized with multidrugresistant mdr acinetobacter baumannii. Genome dynamics of multidrugresistant acinetobacter. The administration of penicillin had a protective effect against isolation of mdr a. Acinetobacter baumannii is an important cause of nosocomial infections worldwide.
485 773 137 503 1284 1084 73 498 651 967 913 981 108 1413 278 615 617 26 1105 423 1476 672 445 1075 837 1199 33 440 709 658